Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study
Clinical trial NCT07542002 · RECRUITING
Trial details
- NCT number
- NCT07542002
- Sponsor
- Ningbo Medical Center Lihuili Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-25
- Primary completion
- 2026-05-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.